The Jury Is Still Out on the Benefits and Harms of Methylphenidate for Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

Bidragets oversatte titel: 基于发病机制治疗遗传性神经发育障碍的未来之路

Ole Jakob Storebø, Erlend Faltinsen, Morris Zwi, Erik Simonsen, Christian Gluud

13 Citationer (Scopus)

Abstract

Much remains unclear about the benefits and harms of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder (ADHD). Between 2012 and 2018, we conducted two Cochrane systematic reviews on methylphenidate for ADHD. This article explores the main findings in relation to evidence-based practice and our current understanding of ADHD.

Bidragets oversatte titel基于发病机制治疗遗传性神经发育障碍的未来之路
OriginalsprogEngelsk
TidsskriftClinical Pharmacology and Therapeutics
Vol/bind104
Udgave nummer4
Sider (fra-til)606-609
ISSN0009-9236
DOI
StatusUdgivet - 13 jul. 2018

Fingeraftryk

Dyk ned i forskningsemnerne om '基于发病机制治疗遗传性神经发育障碍的未来之路'. Sammen danner de et unikt fingeraftryk.

Citationsformater